Dr. Graham presented HyProCure® and the EOTTS procedure to a fully-attended room of approximately 100 distinguished sports medicine doctors from all over the world. His dynamic presentation demonstrated how use of the HyProCure® titanium stent is one of the most effective advances in treatment and prevention of chronic, over-use injuries to the lower extremities.
Physicians were intrigued by the extensive research behind HyProCure® as well as the simplicity that makes it be a life-long solution. “This is great for the sports medicine world. I can’t wait to share this with my professors and fellow doctors,” says Isabel Costa, a medical school resident from Brazil.
Dr. Graham designed HyProCure® to be inserted into a naturally occurring space between the ankle and heel bones in order to realign and stabilize the hind foot. Estimates indicate 20 – 40% of the world’s population is affected by issues related to hind foot instability and are at substantial risk of developing an overuse injury of the lower extremities. Conservatively, half could be treated with HyProCure’s minimally invasive EOTTS procedure by itself or in combination with other simple procedures.
For more information about the HyProCure® procedure, please visit http://AlignMyFeet.com.
GraMedica is a global orthopedic medical device company and leader in the development of life-changing foot and ankle products. Through its sister educational organization, the Graham International Implant Institute, GraMedica is committed to research, training, certification and support on implantology for foot surgeons worldwide. http://gramedica.com/